Trodelvy approved for PBS
BCNA welcomes yesterday's announcement to list Trodelvy® (sacituzumab govitecan) to the Pharmaceutical Benefits Scheme (PBS). Check out the article for full details of this news and eligibility https://www.bcna.org.au/news/2022/03/trodelvy-approved-for-pbs/121Views2likes3CommentsSubsidy for Verzenio (abemaciclib) expanded on the PBS
Hi everyone, I thought some of you may be interested to read about the recent expansion of the Pharmaceutical Benefits Scheme (PBS) listing of Verzenio (abemaciclib) to include its use in combination with Faslodex (fulvestrant). You can read the full details on the BCNA website link below: https://www.bcna.org.au/news/2021/10/subsidy-for-verzenio-abemaciclib-expanded-on-the-pbs/ We recommend talking to your treatment team if you have any questions about abemaciclib or fulvestrant. (This has also been posted in private group 'Living with metastatic breast cancer')41Views0likes0Comments